Epidemiologic Evidence for Adverse Effects of DES Exposure during Pregnancy
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The state of evidence regarding in utero DES exposure with other female genital tract abnormalities, with male genital tract irregularities, with subsequent adverse reproductive experiences, and, among the exposed mothers, with increased risk of breast and other gynecologic cancers is summarized.
Abstract
Abstract This report summarizes the evidence regarding adverse effects of diethylstilbestrol (DES) administration during pregnancy. From the association in 1969 of in utero DES exposure with subsequent increased risk of vaginal cancer in young women, the report includes the state of evidence regarding in utero DES exposure with other female genital tract abnormalities, with male genital tract abnormalities, with subsequent adverse reproductive experiences, and, among the exposed mothers, with increased risk of breast and other gynecologic cancers.
